⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ovarian carcinosarcoma

Every month we try and update this database with for ovarian carcinosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsNCT03641287
Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaNCT00390234
Fallopian Tube ...
Female Reproduc...
Ovarian Carcino...
Ovarian Sarcoma
Recurrent Ovari...
Recurrent Uteri...
Stage III Ovari...
Stage III Uteri...
Stage IV Ovaria...
Stage IV Uterin...
Uterine Carcino...
Uterine Leiomyo...
ziv-aflibercept
18 Years - National Cancer Institute (NCI)
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerNCT00989651
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Carcino...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Bevacizumab
Carboplatin
Cisplatin
Laboratory Biom...
Paclitaxel
Veliparib
18 Years - National Cancer Institute (NCI)
Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsNCT00066651
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsNCT03641287
Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersNCT03924245
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
High Grade Fall...
High Grade Ovar...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Primary Periton...
Recurrent Endom...
Recurrent Ovari...
Recurrent Prima...
Entinostat
Olaparib
18 Years - Vanderbilt-Ingram Cancer Center
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasNCT03449108
Bone Sarcoma
Dedifferentiate...
Giant Cell Tumo...
Malignancy in G...
Malignant Solid...
Ovarian Carcino...
Platinum-Resist...
Poorly Differen...
Recurrent Osteo...
Recurrent Ovari...
Refractory Oste...
Soft Tissue Sar...
Thyroid Gland A...
Thyroid Gland S...
Undifferentiate...
Triple Negative...
Aldesleukin
Autologous Tumo...
Autologous Tumo...
Cyclophosphamid...
Fludarabine
Ipilimumab
Nivolumab
Quality-of-Life...
Questionnaire A...
16 Years - 70 YearsM.D. Anderson Cancer Center
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerNCT01010126
Adult Hepatocel...
Advanced Adult ...
Endometrial Ser...
Localized Non-R...
Lung Carcinoid ...
Malignant Pancr...
Malignant Pancr...
Malignant Pancr...
Malignant Pancr...
Metastatic Dige...
Ovarian Carcino...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Pancreatic Alph...
Pancreatic Beta...
Pancreatic Delt...
Pancreatic G-Ce...
Pancreatic Poly...
Recurrent Adult...
Recurrent Diges...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prima...
Recurrent Uteri...
Regional Digest...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Carcino...
Bevacizumab
Temsirolimus
18 Years - National Cancer Institute (NCI)
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT02101775
Ovarian Brenner...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Undiffe...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Adavosertib
Gemcitabine Hyd...
Laboratory Biom...
Pharmacological...
Placebo Adminis...
Questionnaire A...
18 Years - National Cancer Institute (NCI)
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerNCT00352300
Fallopian Tube ...
Infectious Diso...
Neutropenia
Ovarian Carcino...
Primary Periton...
Stage III Ovari...
Stage IV Ovaria...
Adjuvant Therap...
Carboplatin
Paclitaxel
Pegfilgrastim
18 Years - GOG Foundation
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerNCT00511992
Advanced Ovaria...
Primary Periton...
Ovarian Carcino...
Avastin
Paclitaxel
Cisplatin
18 Years - University of Oklahoma
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerNCT00838656
Fallopian Tube ...
Ovarian Cancer
Primary Periton...
carboplatin
gemcitabine hyd...
paclitaxel
18 Years - 75 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractNCT00003334
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
paclitaxel
pegylated lipos...
- 120 YearsNYU Langone Health
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)NCT03648489
Ovarian Cancer
Ovarian Neoplas...
Ovarian Carcino...
Ovarian Serous ...
Ovarian Endomet...
Ovarian Clear C...
Fallopian Tube ...
Fallopian Tube ...
Primary Periton...
Primary Periton...
Paclitaxel
TAK228
18 Years - Imperial College London
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerNCT00511992
Advanced Ovaria...
Primary Periton...
Ovarian Carcino...
Avastin
Paclitaxel
Cisplatin
18 Years - University of Oklahoma
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic CancerNCT00032162
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
carboplatin
pegylated lipos...
18 Years - AGO Study Group
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractNCT00003334
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
paclitaxel
pegylated lipos...
- 120 YearsNYU Langone Health
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibNCT03651206
Ovarian Carcino...
Endometrial Car...
Niraparib
Niraparib + TSR...
Chemotherapy Dr...
18 Years - ARCAGY/ GINECO GROUP
EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine CarcinosarcomaNCT05619913
Ovarian Carcino...
Uterine Carcino...
Eribulin Mesyla...
Pembrolizumab
18 Years - Australia New Zealand Gynaecological Oncology Group
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant EffusionNCT04919629
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Biopsy
Biospecimen Col...
Pegcetacoplan
Pembrolizumab
Questionnaire A...
18 Years - Roswell Park Cancer Institute
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerNCT00954174
Mixed Mesoderma...
Ovarian Carcino...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Uterin...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Uterin...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Uterin...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Uteri...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Uteri...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Carcino...
Carboplatin
Ifosfamide
Paclitaxel
Quality-of-Life...
18 Years - GOG Foundation
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibNCT03651206
Ovarian Carcino...
Endometrial Car...
Niraparib
Niraparib + TSR...
Chemotherapy Dr...
18 Years - ARCAGY/ GINECO GROUP
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)NCT03648489
Ovarian Cancer
Ovarian Neoplas...
Ovarian Carcino...
Ovarian Serous ...
Ovarian Endomet...
Ovarian Clear C...
Fallopian Tube ...
Fallopian Tube ...
Primary Periton...
Primary Periton...
Paclitaxel
TAK228
18 Years - Imperial College London
MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal CancerNCT02364713
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Gemcitabine Hyd...
Laboratory Biom...
Oncolytic Measl...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Topotecan Hydro...
18 Years - Mayo Clinic
A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerNCT05902988
Advanced Solid ...
High Grade Sero...
Squamous Non-sm...
Triple Negative...
Gastric Adenoca...
Colorectal Aden...
Esophageal Squa...
Esophageal Aden...
Gastroesophagea...
Transitional Ce...
Head and Neck S...
Ovarian Carcino...
Uterine Carcino...
Uterine Serous ...
Endometrium Can...
Chromosomal Ins...
VLS-1488
18 Years - Volastra Therapeutics, Inc.
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT02101775
Ovarian Brenner...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Undiffe...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Adavosertib
Gemcitabine Hyd...
Laboratory Biom...
Pharmacological...
Placebo Adminis...
Questionnaire A...
18 Years - National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerNCT00483782
Fallopian Tube ...
Ovarian Cancer
Primary Periton...
bevacizumab
carboplatin
paclitaxel
questionnaire a...
study of socioe...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyNCT01080521
Cognitive Side ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Carcino...
Ovarian Chorioc...
Ovarian Clear C...
Ovarian Dysgerm...
Ovarian Embryon...
Ovarian Endomet...
Ovarian Mixed G...
Ovarian Mucinou...
Ovarian Polyemb...
Ovarian Sarcoma
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Teratom...
Ovarian Yolk Sa...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Cognitive Asses...
Quality-of-Life...
18 Years - GOG Foundation
MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal CancerNCT02364713
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Gemcitabine Hyd...
Laboratory Biom...
Oncolytic Measl...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Topotecan Hydro...
18 Years - Mayo Clinic
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant EffusionNCT04919629
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Biopsy
Biospecimen Col...
Pegcetacoplan
Pembrolizumab
Questionnaire A...
18 Years - Roswell Park Cancer Institute
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersNCT02020707
Cervical Adenoc...
Cervical Adenos...
Cervical Adenos...
Cervical Carcin...
Cervical Squamo...
Clinical Stage ...
Endometrial Ade...
Endometrial Cle...
Endometrial End...
Endometrial Mix...
Endometrial Muc...
Endometrial Ser...
Endometrial Und...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Femal...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Perit...
Malignant Solid...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian High Gr...
Ovarian Mucinou...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Sensit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Unresectable Me...
Uterine Corpus ...
Bevacizumab
Laboratory Biom...
Nab-paclitaxel
Pharmacological...
18 Years - Mayo Clinic
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: